How to Build Clinical Safety for Biotechs Without a Full Department
Clinical safety management becomes essential for biotech companies earlier than many anticipate. Regulators require clear safety oversight, structured reporting, and reliable adverse event management even in early development. However, most companies at this stage...
Clinical Safety Management in Pharma: How to Manage Risk Across the Drug Development Lifecycle
Clinical trial safety management is essential across the drug development lifecycle. From first-in-human studies to late-phase development and post-marketing commitments, companies need a clear system for identifying, assessing, documenting, and acting on safety...
Biomapas Insights: Clinical Site Selection for Early Phase Oncology Studies
In this episode, Artūras Pažera, Senior Clinical Project Manager at Biomapas, speaks with Jean‑Luc Béjot, an independent consultant with more than 35 years of international experience in clinical development, clinical operations, and medical affairs. Together, they...
Case Study: Specialised Rescue Studies in Georgia
Discover how we successfully supported late‑phase clinical trials in Georgia by overcoming operational constraints, accelerating study start‑up, and restoring delivery confidence in complex research environments. This case study highlights three real‑world success...
